Adjunctive and supportive measures for community-acquired pneumonia

G. W. Waterer, Richard G Wunderink

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The widespread introduction of penicillin in the 1940s resulted in a substantial reduction in mortality from community-acquired pneumonia (CAP). However, despite significant advances in medical science, only a small improvement has occurred since, particularly in patients with bacteremic pneumococcal pneumonia [1, 2]. Even modern intensive care has only made a small difference to the mortality in patients with severe pneumonia [3, 4]. While the aging population, increased number of patients with severe co-morbid illnesses, and the human immunodeficiency virus (HIV) epidemic have certainly contributed to the persistently high mortality rate [2, 5, 6], apparently healthy, immunocompetent patients continue to die from CAP. Disturbingly, a recent British Thoracic Society study concluded that no available therapy could substantially reduce the mortality rate from severe CAP in young adults [7].

Original languageEnglish (US)
Title of host publicationInfectious Diseases in Critical Care
PublisherSpringer Berlin Heidelberg
Pages413-419
Number of pages7
ISBN (Print)9783540344056
DOIs
StatePublished - Dec 1 2007

Fingerprint

Pneumonia
Mortality
Pneumococcal Pneumonia
Critical Care
Penicillins
Young Adult
HIV
Population
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Waterer, G. W., & Wunderink, R. G. (2007). Adjunctive and supportive measures for community-acquired pneumonia. In Infectious Diseases in Critical Care (pp. 413-419). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-540-34406-3_38
Waterer, G. W. ; Wunderink, Richard G. / Adjunctive and supportive measures for community-acquired pneumonia. Infectious Diseases in Critical Care. Springer Berlin Heidelberg, 2007. pp. 413-419
@inbook{a3808d1d420a431fa86454cb787a9cc8,
title = "Adjunctive and supportive measures for community-acquired pneumonia",
abstract = "The widespread introduction of penicillin in the 1940s resulted in a substantial reduction in mortality from community-acquired pneumonia (CAP). However, despite significant advances in medical science, only a small improvement has occurred since, particularly in patients with bacteremic pneumococcal pneumonia [1, 2]. Even modern intensive care has only made a small difference to the mortality in patients with severe pneumonia [3, 4]. While the aging population, increased number of patients with severe co-morbid illnesses, and the human immunodeficiency virus (HIV) epidemic have certainly contributed to the persistently high mortality rate [2, 5, 6], apparently healthy, immunocompetent patients continue to die from CAP. Disturbingly, a recent British Thoracic Society study concluded that no available therapy could substantially reduce the mortality rate from severe CAP in young adults [7].",
author = "Waterer, {G. W.} and Wunderink, {Richard G}",
year = "2007",
month = "12",
day = "1",
doi = "10.1007/978-3-540-34406-3_38",
language = "English (US)",
isbn = "9783540344056",
pages = "413--419",
booktitle = "Infectious Diseases in Critical Care",
publisher = "Springer Berlin Heidelberg",

}

Waterer, GW & Wunderink, RG 2007, Adjunctive and supportive measures for community-acquired pneumonia. in Infectious Diseases in Critical Care. Springer Berlin Heidelberg, pp. 413-419. https://doi.org/10.1007/978-3-540-34406-3_38

Adjunctive and supportive measures for community-acquired pneumonia. / Waterer, G. W.; Wunderink, Richard G.

Infectious Diseases in Critical Care. Springer Berlin Heidelberg, 2007. p. 413-419.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Adjunctive and supportive measures for community-acquired pneumonia

AU - Waterer, G. W.

AU - Wunderink, Richard G

PY - 2007/12/1

Y1 - 2007/12/1

N2 - The widespread introduction of penicillin in the 1940s resulted in a substantial reduction in mortality from community-acquired pneumonia (CAP). However, despite significant advances in medical science, only a small improvement has occurred since, particularly in patients with bacteremic pneumococcal pneumonia [1, 2]. Even modern intensive care has only made a small difference to the mortality in patients with severe pneumonia [3, 4]. While the aging population, increased number of patients with severe co-morbid illnesses, and the human immunodeficiency virus (HIV) epidemic have certainly contributed to the persistently high mortality rate [2, 5, 6], apparently healthy, immunocompetent patients continue to die from CAP. Disturbingly, a recent British Thoracic Society study concluded that no available therapy could substantially reduce the mortality rate from severe CAP in young adults [7].

AB - The widespread introduction of penicillin in the 1940s resulted in a substantial reduction in mortality from community-acquired pneumonia (CAP). However, despite significant advances in medical science, only a small improvement has occurred since, particularly in patients with bacteremic pneumococcal pneumonia [1, 2]. Even modern intensive care has only made a small difference to the mortality in patients with severe pneumonia [3, 4]. While the aging population, increased number of patients with severe co-morbid illnesses, and the human immunodeficiency virus (HIV) epidemic have certainly contributed to the persistently high mortality rate [2, 5, 6], apparently healthy, immunocompetent patients continue to die from CAP. Disturbingly, a recent British Thoracic Society study concluded that no available therapy could substantially reduce the mortality rate from severe CAP in young adults [7].

UR - http://www.scopus.com/inward/record.url?scp=84891980357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891980357&partnerID=8YFLogxK

U2 - 10.1007/978-3-540-34406-3_38

DO - 10.1007/978-3-540-34406-3_38

M3 - Chapter

SN - 9783540344056

SP - 413

EP - 419

BT - Infectious Diseases in Critical Care

PB - Springer Berlin Heidelberg

ER -

Waterer GW, Wunderink RG. Adjunctive and supportive measures for community-acquired pneumonia. In Infectious Diseases in Critical Care. Springer Berlin Heidelberg. 2007. p. 413-419 https://doi.org/10.1007/978-3-540-34406-3_38